113 related articles for article (PubMed ID: 8287221)
61. p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients.
Bonnefoi H; Ducraux A; Movarekhi S; Pelte MF; Bongard S; Lurati E; Iggo R
Br J Cancer; 2002 Mar; 86(5):750-5. PubMed ID: 11875738
[TBL] [Abstract][Full Text] [Related]
62. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.
Latronico AC; Pinto EM; Domenice S; Fragoso MC; Martin RM; Zerbini MC; Lucon AM; Mendonca BB
J Clin Endocrinol Metab; 2001 Oct; 86(10):4970-3. PubMed ID: 11600572
[TBL] [Abstract][Full Text] [Related]
63. [Perspectives of practical application for studies of gene p53].
Schlichtholz B; Soussi T
Postepy Biochem; 1994; 40(4):211-21. PubMed ID: 7845878
[No Abstract] [Full Text] [Related]
64. [The methodological specificity of PCR-test of gene p53 in plasma and blood cell DNA of oncological patients].
Bartnovskiĭ AE; Belokhvostov AS; Abramov AA; Likhin FA
Klin Lab Diagn; 2003 Nov; (11):19-23. PubMed ID: 14708367
[TBL] [Abstract][Full Text] [Related]
65. Low frequency of the p53 gene mutations in neuroblastoma.
Hosoi G; Hara J; Okamura T; Osugi Y; Ishihara S; Fukuzawa M; Okada A; Okada S; Tawa A
Cancer; 1994 Jun; 73(12):3087-93. PubMed ID: 8200007
[TBL] [Abstract][Full Text] [Related]
66. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Suzuki Y; Tamura G; Satodate R; Fujioka T
Jpn J Cancer Res; 1992 Mar; 83(3):233-5. PubMed ID: 1582882
[TBL] [Abstract][Full Text] [Related]
67. Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia.
Chu LL; Rutteman GR; Kong JM; Ghahremani M; Schmeing M; Misdorp W; van Garderen E; Pelletier J
Breast Cancer Res Treat; 1998 Jul; 50(1):11-25. PubMed ID: 9802616
[TBL] [Abstract][Full Text] [Related]
68. p53 gene mutations in multiple myeloma.
Owen RG; Davis SA; Randerson J; Rawstron AC; Davies F; Child JA; Jack AS; Morgan GJ
Mol Pathol; 1997 Feb; 50(1):18-20. PubMed ID: 9208809
[TBL] [Abstract][Full Text] [Related]
69. A p53 gene mutation in malignant fibrous histiocytoma associated with bone infarction.
Yamamoto Y; Takakuwa Y; Kuroda M; Nakashima H; Washimi Y; Ishimura D; Yamada H
Tohoku J Exp Med; 2011 Nov; 225(3):215-20. PubMed ID: 22041521
[TBL] [Abstract][Full Text] [Related]
70. Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood.
Schiffer D; Cavalla P; Di Sapio A; Giordana MT; Mauro A
Childs Nerv Syst; 1995 Sep; 11(9):517-22. PubMed ID: 8529218
[TBL] [Abstract][Full Text] [Related]
71. Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma.
Kaneko H; Sugita K; Kiyokawa N; Iizuka K; Takada K; Saito M; Yoshimoto K; Itakura M; Kokai Y; Fujimoto J
Leuk Lymphoma; 1996 May; 21(5-6):449-55. PubMed ID: 9172810
[TBL] [Abstract][Full Text] [Related]
72. In situ detection of specific p53 mutations in cultured cells using the amplification refractory mutation system polymerase chain reaction.
Low EO; Gibbins JR; Walker DM
Diagn Mol Pathol; 2000 Dec; 9(4):210-20. PubMed ID: 11129445
[TBL] [Abstract][Full Text] [Related]
73. P53 mutations in thyroid carcinoma: tidings from an old foe.
Farid NR
J Endocrinol Invest; 2001; 24(7):536-45. PubMed ID: 11508790
[TBL] [Abstract][Full Text] [Related]
74. Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA.
Soto D; Sukumar S
PCR Methods Appl; 1992 Aug; 2(1):96-8. PubMed ID: 1490183
[No Abstract] [Full Text] [Related]
75. Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA.
Lohmann DR; Funk A; Niedermeyer HP; Häupel S; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(5):293-6. PubMed ID: 8287125
[TBL] [Abstract][Full Text] [Related]
76. The p53 status in juvenile chronic arthritis and rheumatoid arthritis.
Taubert H; Thamm B; Meye A; Bartel F; Rost AK; Heidenreich D; John V; Brandt J; Bache M; Würl P; Schmidt H; Riemann D
Clin Exp Immunol; 2000 Nov; 122(2):264-9. PubMed ID: 11091284
[TBL] [Abstract][Full Text] [Related]
77. Nonisotopic SSCP and competitive PCR for DNA quantification: p53 in breast cancer cells.
Yap EP; McGee JO
Nucleic Acids Res; 1992 Jan; 20(1):145. PubMed ID: 1738597
[No Abstract] [Full Text] [Related]
78. Artifactual p53 point mutations: possible effect of gene secondary structure on PCR and direct sequence analysis.
Mor O; Grossman Z; Jakobovitz O; Brok-Simoni F; Rechavi G
Lancet; 1992 Nov; 340(8829):1236. PubMed ID: 1359315
[No Abstract] [Full Text] [Related]
79. [Role of the p53 gene in human malignant tumors. A major discovery in oncology].
Soussi T
Rev Prat; 1993 Dec; 43(19):2531-5. PubMed ID: 8153537
[No Abstract] [Full Text] [Related]
80. [Detection of micrometastasis in the patients with malignant tumors].
Shimada Y
Nihon Geka Hokan; 1994 Nov; 63(6):197-8. PubMed ID: 7575083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
